| AGE | Methylated | Unmethylated | Total | P value |
| AGE ≤ 50 | 15 (42.1) | 4 | 19 |
|
| AGE > 50 | 51 (19.7) | 10 | 61 |
|
| STAGE |
|
|
| p > 0.05 |
| STAGEII | 25 (%38) | 5 | 30 |
|
| STAGEIII | 37 (%56) | 7 | 44 |
|
| STAGEIV | 4 (%6) | 2 | 6 |
|
| LYMPH NODE |
|
|
|
|
| + | 57 (86.4) | 11 | 68 | P < 0.001 |
| - | 9 (13.6) | 3 | 12 |
|
| ER |
|
|
|
|
| + | 44 (66.7) |
10 | 54 | P < 0.05 |
| - | 22 (33.3) | 4 | 26 |
|
| PR |
|
|
| Nonevaluated |
| + | 33 (%50) | 9 | 42 |
|
| - | 33 (%50) | 5 | 38 |
|
| HER2/neu |
|
|
|
|
| + | 26 (39.4) | 4 | 30 |
|
| - | 40 (60.6) | 10 | 50 | P < 0.05 |